Vitreous Injection New Option for Postoperative Cataract Care
Medscape,
In an effort to overcome issues with noncompliance, a new study evaluated the efficacy of transzonular vitreous injection…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
BioTech Gate,
/PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
Ticker Tech,
/PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
Ariva,
/PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
Benzinga,
Journal of Clinical Ophthalmology reports 'strong patient preference' for Imprimis Pharmaceuticals' Dropless Therapy®…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
Yahoo! Finance Singapore,
/PRNewswire/ -- Imprimis Pharmaceuticals, Inc. ( IMMY ), a pharmaceutical company dedicated to making drugs affordable again…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
Minyanville: Finance ,
SAN DIEGO, July 22, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. ( NASDAQ: IMMY ), a pharmaceutical company dedicated to…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
PR Newswire,
Journal of Clinical Ophthalmology reports 'strong patient preference' for Imprimis Pharmaceuticals' Dropless Therapy®…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
Yahoo! Finance USA,
/PRNewswire/ -- Imprimis Pharmaceuticals, Inc. ( IMMY ), a pharmaceutical company dedicated to making drugs affordable again…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
Bioportfolio,
SAN DIEGO, July 22, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to…
Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops
NASDAQ,
/PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), a pharmaceutical company dedicated to making drugs affordable…
Imprimis Release: Peer-Reviewed Study Of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared To Drops
Biospace,
/PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable…